Cipla acquires two US based generic drug companies InvaGen and Exelan.

Q.  Which company/ies has Cipla recently acquired on February 18, 2016?
- Published on 19 Feb 16

a. InvaGen
b. Newton
c. Exelan
d. a and c
e. b and c

ANSWER: a and c
 
Cipla Limited has acquired two US generic drug firms InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc to enhance revenue and introduce fresh products for coping with diseases such as cancer and diabetes in what is the largest pharma market in the world. Cipla closed the transaction through completely owned subsidiary Cipla EU Ltd, as per the statement. This marks the second biggest acquisition in Cipla’s 8 decade history.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲